Roche’s CellCept Gains “Black Box” Warning On Use During Pregnancy
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA reinforces warning on increased risk of miscarriage, congenital deformities in light of postmarketing data from Roche, firm tells “The Pink Sheet” DAILY.